{
    "clinical_study": {
        "@rank": "19", 
        "brief_summary": {
            "textblock": "To compare the effects of megestrol acetate and placebo on body weight, anorexia, cachexia,\n      calorie intake, and nutritional parameters of patients with a confirmed diagnosis of AIDS.\n      To characterize dose response in relation to weight gain. To determine whether megestrol\n      acetate relative to placebo improves the perception of well-being among AIDS patients with\n      cachexia. To evaluate megestrol acetate's effect on immune function via skin test\n      reactivity, T4/T8 ratio, and total lymphocytes."
        }, 
        "brief_title": "A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition", 
        "condition": [
            "Anorexia", 
            "Cachexia", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Anorexia", 
                "Cachexia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patient must have:\n\n          -  Confirmed diagnosis of AIDS (CDC definition).\n\n          -  Documented weight loss or anorexia.\n\n          -  Life expectancy = or > 20 weeks.\n\n          -  The perception that the weight loss is a detriment to their well-being.\n\n          -  Ability to provide informed consent, read and write English.\n\n        Prior Medication:\n\n        Allowed:\n\n          -  Ganciclovir.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following are excluded:\n\n          -  Dementia or evidence of mental incompetence which would preclude compliance with the\n             protocol.\n\n          -  Diarrhea defined as 5 or more watery stools per day for at least 7 days.\n\n          -  Active uncontrolled systemic infections at the start of treatment.\n\n          -  (Patients may not be entered for at least 2 weeks after acute infection.) Clinical or\n             radiologic evidence of ascites or pleural effusions.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Therapy designed to treat the underlying HIV infection or which may have a major\n             impact on appetite and/or weight gain.\n\n          -  Patients who have been started on zidovudine (AZT) within eight weeks. (Patients may\n             have been previously treated with AZT and failed or may currently be receiving AZT\n             for at least 8 weeks.)\n\n        Patients with the following are excluded:\n\n          -  Obstruction to food intake or impaired digestive/absorptive functions.\n\n          -  Contraindications to high-dose megestrol acetate (poorly controlled hypertension or\n             heart failure or deep vein thrombosis).\n\n          -  Inability to consent or be available for close follow-up.\n\n          -  Active systemic infections at the start of treatment.\n\n          -  Patients may not be started on any therapy designed to treat the underlying HIV\n             infection or which may have a major impact on appetite and/or weight gain.\n\n          -  Clinical or radiologic evidence of ascites or pleural effusions.\n\n          -  Patients may not be started on any therapy designed to treat the underlying HIV\n             infection or which may have a major impact on appetite and/or weight gain.\n\n          -  Patients who have been hospitalized or have suffered an exacerbation of their illness\n             associated with weight loss within the past 2 weeks are excluded.\n\n          -  Menstruating female patients are excluded.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Corticosteroids.\n\n          -  Anabolic steroids.\n\n          -  Marijuana.\n\n          -  Megestrol acetate.\n\n          -  Patients who have been started on zidovudine (AZT) within 8 weeks. (Patients may have\n             been previously treated with AZT and failed or may currently be receiving AZT for at\n             least 8 weeks.) History of substance abuse and questionable current and future\n             abstinence."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "id_info": {
            "nct_id": "NCT00002300", 
            "org_study_id": "025A", 
            "secondary_id": "MEG8807"
        }, 
        "intervention": {
            "intervention_name": "Megestrol acetate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Megestrol", 
                "Megestrol Acetate"
            ]
        }, 
        "keyword": [
            "T-Lymphocytes", 
            "Megestrol", 
            "Dose-Response Relationship, Drug", 
            "Acquired Immunodeficiency Syndrome", 
            "Anorexia", 
            "Cachexia"
        ], 
        "lastchanged_date": "October 1, 2007", 
        "link": [
            {
                "description": "BMS Clinical Trials Disclosure", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35233"
                    }, 
                    "name": "Birmingham Veterans Administration Med Ctr / Univ of Alabama"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Long Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90801"
                    }, 
                    "name": "Dr NS Tchekmedyian"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90067"
                    }, 
                    "name": "Dr Stephen J Gabin Jr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rancho Mirage", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92270"
                    }, 
                    "name": "Eisenhower Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80204"
                    }, 
                    "name": "Denver Public Health Dept"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20037"
                    }, 
                    "name": "George Washington Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20422"
                    }, 
                    "name": "Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33125"
                    }, 
                    "name": "Miami Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern Univ Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "12203"
                    }, 
                    "name": "Albany Med College / AIDS Treatment Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10010"
                    }, 
                    "name": "Community Research Initiative on AIDS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Mem Sloan - Kettering Cancer Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10011"
                    }, 
                    "name": "Saint Vincent's Hosp and Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Univ of Pennsylvania"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78284"
                    }, 
                    "name": "Audie L Murphy Veterans Administration Hosp"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Phase II-III Randomized Double-Blind Study Comparing Megestrol Acetate at 100, 400, and 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "reference": {
            "PMID": "9066597", 
            "citation": "Strang P. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review). Anticancer Res. 1997 Jan-Feb;17(1B):657-62. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002300"
        }, 
        "source": "Bristol-Myers Squibb", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2007"
    }, 
    "geocoordinates": {
        "Albany Med College / AIDS Treatment Ctr": "42.653 -73.756", 
        "Audie L Murphy Veterans Administration Hosp": "29.424 -98.494", 
        "Birmingham Veterans Administration Med Ctr / Univ of Alabama": "33.521 -86.802", 
        "Community Research Initiative on AIDS": "40.714 -74.006", 
        "Denver Public Health Dept": "39.739 -104.985", 
        "Dr NS Tchekmedyian": "33.804 -118.158", 
        "Dr Stephen J Gabin Jr": "34.052 -118.244", 
        "Eisenhower Med Ctr": "33.74 -116.413", 
        "George Washington Univ Med Ctr": "38.895 -77.036", 
        "Mem Sloan - Kettering Cancer Ctr": "40.714 -74.006", 
        "Miami Veterans Administration Med Ctr": "25.789 -80.226", 
        "Northwestern Univ Med School": "41.878 -87.63", 
        "Saint Vincent's Hosp and Med Ctr": "40.714 -74.006", 
        "Univ of Pennsylvania": "39.952 -75.164", 
        "Veterans Administration Med Ctr": "38.895 -77.036"
    }
}